CASP3 and cancer: Interestingly, DBeQ mobilizes the executioner caspases 3 and 7 and induces apoptosis more rapidly than the proteasome inhibitor MG132,22 thus highlighting p97 as a potentially suitable target for cancer chemotherapy.